For example, GPR40 agonists have been shown to decrease the frequency of spontaneous EPSCs (excitatory postsynaptic currents) in dorsal horn neurons of the spinal cord of inflammatory and neuropathic pain model mice [56]. The gene discussed is FFAR1; the disease is neuropathic pain.